Lv11
20 积分 2025-02-06 加入
The intriguing overall survival results of the PRIMA trial
3小时前
求助中
Survival Analysis and Prognostic Factors in Advanced NSCLC Harboring EGFR PACC Mutations: A Multicenter Retrospective Study
12天前
已完结
HTA9 A Matching-Adjusted Indirect Comparison (MAIC) of Rucaparib vs. Niraparib in the Maintenance Treatment of Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer (aOC) After Response to First-Line Platinum-Based Chemotherapy
27天前
已关闭
490MO Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) in Chinese patients with breast cancer susceptibility gene (BRCA) altered metastatic castration-sensitive prostate cancer (mCSPC): Subgroup analysis of the phase III AMPLITUDE trial
27天前
已关闭
Finerenone’s safety and efficacy in membranous nephropathy: an emerging perspective
1个月前
已完结
Breaking barriers in ocular drug delivery for Uveitis: Advanced drug delivery systems, challenges and future prospects
1个月前
已完结
Efficacy and safety of intravenous efgartigimod for chronic inflammatory demyelinating polyneuropathy: A case series real-world study
1个月前
已完结
Unusual Presentation of Lung Adenocarcinoma as Male Breast Lump and Pathological Femoral Fracture: A Surgeon’s Perspective
2个月前
已完结
Multi-Institution Analysis of Tarlatamab for the Treatment of EGFR -Mutant Transformed Small Cell Lung Cancer
2个月前
已完结
Olaparib in Patients With Solid Tumors With BRCA1/2 Alterations: Results From The Targeted Agent and Profiling Utilization Registry (TAPUR) Study
2个月前
已关闭
皖公网安备34019202002308
